William Benton Jones, SVP, Pharmaceutical Development at Corvus Pharmaceuticals, holds 153.77K shares in Corvus Pharmaceuticals (Ticker: CRVS). Most recently, William Benton Jones Bought $20,000 shares of Corvus Pharmaceuticals on May 07, 2024 for an estimated value of 34.60K.
What is the percentage of profitable transactions made by William Benton Jones?
The percentage of profitable transactions made by William Benton Jones is 100%.
What is the average return per transaction made by William Benton Jones?
The average return per transaction made by William Benton Jones is 245.80%.
What stocks does William Benton Jones hold?
William Benton Jones holds: CRVS stocks.
What was William Benton Jones’s latest transaction?
William Benton Jones latest transaction was an Informative Buy of $34.60K.
What was William Benton Jones's most profitable transaction?
William Benton Jones’s most profitable transaction was an Informative Buy of CRVS stock on May 7, 2024. The return on the trade was 391.60%.
What is William Benton Jones's role in Corvus Pharmaceuticals?
William Benton Jones's role in Corvus Pharmaceuticals is SVP, Pharmaceutical Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.